Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples

The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the recent and devastating 2014–2016 outbreak of Ebola virus (EBOV) disease in Guinea, Sierra Leone, and Liberia that resulted in more than 10,000 casualties. Such a vaccine would need to be vetted through a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudge, Thomas L., Sankovich, Karen A., Niemuth, Nancy A., Anderson, Michael S., Badorrek, Christopher S., Skomrock, Nick D., Cirimotich, Chris M., Sabourin, Carol L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472792/
https://www.ncbi.nlm.nih.gov/pubmed/30998735
http://dx.doi.org/10.1371/journal.pone.0215457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472792/
https://www.ncbi.nlm.nih.gov/pubmed/30998735
http://dx.doi.org/10.1371/journal.pone.0215457

Ejemplares similares